Agilent Technologies (A)
(Delayed Data from NYSE)
$151.28 USD
+3.52 (2.38%)
Updated May 14, 2024 04:00 PM ET
After-Market: $151.23 -0.05 (-0.03%) 6:12 PM ET
3-Hold of 5 3
D Value B Growth D Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
A 151.28 +3.52(2.38%)
Will A be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for A based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for A
NICE to Report Q1 Earnings: Will a Strong Portfolio Aid Growth?
What's in Store for Applied Materials (AMAT) in Q2 Earnings?
A: What are Zacks experts saying now?
Zacks Private Portfolio Services
Take-Two (TTWO) to Report Q4 Earnings: What's in Store?
Earnings Growth & Price Strength Make Agilent Technologies (A) a Stock to Watch
Earnings Growth & Price Strength Make Agilent Technologies (A) a Stock to Watch
Other News for A
Agilent Technologies Inc. stock rises Tuesday, outperforms market
Agilent Technologies Inc (A)'s Winning Formula: Financial Metrics and Competitive Strengths
W. P. Carey Has Crashed: Buy, Hold, Or Sell?
My Dividend Growth Portfolio: Selling Bio-Pharma And Buying More Big-Tech
$100 Invested In Agilent Technologies 10 Years Ago Would Be Worth This Much Today